Buscar
03/03/2026
FOLFIRI after failure of platinum-based chemotherapy in poor prognostic neuroendocrine neoplasms of gastroenteropancreatic origin-A real-world evidence study
Hayes, A, Mukherjee, U, OMahony, LF, Modi, S, von Stempel, C, Luong, T, Paez, D, Nageshwaran, S, Ganguli, S, Toumpanakis, C, Caplin, M, Krell, D. FOLFIRI after failure of platinum-based chemotherapy in poor prognostic neuroendocrine neoplasms of gastroenteropancreatic origin-A real-world evidence study. JOURNAL OF NEUROENDOCRINOLOGY. 2026; 38DOI:. PMID:. IF:4.100(Q1/3D).
02/03/2026
From data to treatment plan: An AI-driven path for automated breast radiotherapy planning
Gallego, P, Ambroa, E, Pérez-Alija, J, Julià, JC, Jornet, N, Matas, A, Anson, C, Mera, A, Tejedor, N, Vivancos, H, Ruiz, A, Barceló, M, Dominguez, A, Riu, V, Roda, J, Carrasco, P, Balocco, S, Díaz, O. From data to treatment plan: An AI-driven path for automated breast radiotherapy planning. Journal of Applied Clinical Medical Physics. 2026; 27(3)DOI:10.1002/acm2.70491. PMID:41769854. IF:2.200(Q2/5D).
02/03/2026
Validation of performance of Spanish version of PURE-4 questionnaire for early identification of psoriatic arthritis after 1 year of follow-up in patients with psoriasis
Queiro-Silva, R, López-Ferrer, A, Farrés, MFI, Rivera-Díaz, R, Vidal-Sarro, D, Fernández-Freire, LR, de la Cueva-Dobao, P, Santos-Juanes, J, Rocamora-Duran, V, Gómez-Labrador, L, Belinchón-Romero, I. Validation of performance of Spanish version of PURE-4 questionnaire for early identification of psoriatic arthritis after 1 year of follow-up in patients with psoriasis. PLoS One. 2026; 21(3)DOI:10.1371/journal.pone.0342498. PMID:41770732. IF:2.600(Q2/4D).
01/03/2026
Binding of human low-density lipoproteins to type-I collagen is synergistic with the pro-atherogenic lipoprotein remodeling
Jayaraman, S, Choi, K, Pérez, A, Miñambres, I, Sánchez-Quesada, JL, Gursky, O. Binding of human low-density lipoproteins to type-I collagen is synergistic with the pro-atherogenic lipoprotein remodeling. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2026; 1872(3)DOI:10.1016/j.bbadis.2025.168142. PMID:41419069. IF:4.200(Q1/2D).